Financhill
Back

Exponent Vs. Novo Nordisk AS Industry Stock Comparison

Sell
41

EXPO
Exponent

Last Price:
$89.09
Seasonality Move:
5.61%
Sell
25

NVO
Novo Nordisk AS

Last Price:
$86.31
Seasonality Move:
6.68%
Sell
41
Exponent (EXPO) is a Sell

Is Exponent a Buy, Sell or Hold?

  • The current Exponent [EXPO] share price is $89.25. The Score for EXPO is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • EXPO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $85.64. The Score for NVO is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EXPO Stock Price Chart

What is Exponent's stock price today?

  • The Exponent share price today is $89.25
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EXPO is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $85.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.

EXPO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.49 Sell
Relative Strength Index (14 RSI): 39.47 Sell
Chaikin Money Flow: 201807 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (88.68 - 95.48) Sell
Bollinger Bands (100): (94.14 - 110.14) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.06 Sell
Relative Strength Index (14 RSI): 31.71 Sell
Chaikin Money Flow: 6521757 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (86.72 - 109.1) Sell
Bollinger Bands (100): (99.51 - 129.55) Sell

EXPO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 88.51 Buy
20-day SMA: 90.89 Sell
50-day SMA: 95.5 Sell
200-day SMA: 97.77 Sell
8-day EMA: 88.75 Buy
20-day EMA: 90.84 Sell
50-day EMA: 95.28 Sell
200-day EMA: 97.2 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 86.04 Sell
20-day SMA: 94.95 Sell
50-day SMA: 102.54 Sell
200-day SMA: 123.74 Sell
8-day EMA: 86.81 Sell
20-day EMA: 92.64 Sell
50-day EMA: 101.62 Sell
200-day EMA: 114.8 Sell

Exponent Earnings Growth & EXPO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and an increase next year of $0.03 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.75 per share, and an increase next year of $0.54 per share.

Exponent Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):